XBiotech Inc
NASDAQ:XBIT
XBiotech Inc
NASDAQ:XBIT
Price:
2.36
USD
2.61%
Market Closed
Market Cap:
$72m
Balance Sheet
Balance Sheet Decomposition
XBiotech Inc
XBiotech Inc
Balance Sheet Decomposition is not available for
XBiotech Inc
XBiotech Inc
Balance Sheet
XBiotech Inc
XBiotech Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
4
|
7
|
57
|
91
|
34
|
32
|
16
|
715
|
237
|
237
|
157
|
200
|
173
|
|
| Cash Equivalents |
4
|
7
|
57
|
91
|
34
|
32
|
16
|
715
|
237
|
237
|
157
|
200
|
173
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
86
|
9
|
2
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
1
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
9
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
2
|
3
|
2
|
1
|
2
|
3
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
4
|
8
|
58
|
93
|
37
|
33
|
17
|
716
|
326
|
247
|
220
|
202
|
175
|
|
| PP&E Net |
4
|
3
|
4
|
16
|
30
|
30
|
27
|
25
|
27
|
28
|
26
|
25
|
25
|
|
| PP&E Gross |
4
|
3
|
4
|
16
|
30
|
30
|
27
|
25
|
27
|
28
|
26
|
25
|
25
|
|
| Accumulated Depreciation |
3
|
4
|
4
|
5
|
5
|
7
|
9
|
12
|
13
|
16
|
17
|
18
|
20
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
75
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
11
+31%
|
62
+460%
|
109
+76%
|
67
-39%
|
63
-6%
|
44
-30%
|
817
+1 744%
|
354
-57%
|
275
-22%
|
246
-11%
|
227
-8%
|
199
-12%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
5
|
4
|
2
|
2
|
2
|
3
|
2
|
2
|
3
|
2
|
|
| Accrued Liabilities |
1
|
0
|
2
|
2
|
4
|
1
|
1
|
4
|
1
|
1
|
2
|
4
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
54
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
3
|
6
|
8
|
3
|
3
|
60
|
4
|
4
|
4
|
6
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Total Liabilities |
1
N/A
|
1
-27%
|
3
+288%
|
6
+103%
|
8
+27%
|
3
-65%
|
3
+4%
|
61
+2 010%
|
5
-92%
|
6
+14%
|
6
-2%
|
8
+36%
|
17
+117%
|
|
| Equity | ||||||||||||||
| Common Stock |
69
|
82
|
152
|
234
|
242
|
278
|
279
|
325
|
250
|
262
|
267
|
271
|
273
|
|
| Retained Earnings |
62
|
71
|
93
|
131
|
183
|
217
|
238
|
431
|
98
|
5
|
28
|
52
|
91
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
|
| Total Equity |
7
N/A
|
10
+38%
|
59
+478%
|
103
+75%
|
59
-43%
|
60
+2%
|
41
-31%
|
756
+1 725%
|
349
-54%
|
269
-23%
|
240
-11%
|
219
-9%
|
182
-17%
|
|
| Total Liabilities & Equity |
9
N/A
|
11
+31%
|
62
+460%
|
109
+76%
|
67
-39%
|
63
-6%
|
44
-30%
|
817
+1 744%
|
354
-57%
|
275
-22%
|
246
-11%
|
227
-8%
|
199
-12%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
32
|
32
|
32
|
32
|
33
|
35
|
36
|
42
|
29
|
30
|
30
|
30
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
